First Real-World Observational Study of the JADA® System, a Medical Device to Control Postpartum Hemorrhage (PPH), Published in ACOG's Obstetrics & Gynecology

JADA Rapidly and Effectively Controlled Bleeding Due to PPH,1 Reinforcing Pivotal Study Results1


PPH is a Significant Cause of Maternal Morbidities in the U.S.2,3,4,5


New Exploratory Post-Hoc...

Related Keywords

Jersey City ,New Jersey ,United States ,Maryland ,New York ,Patricia Carney ,Dena Goffman ,Carvalho Pacagnella ,Thromb Haemost ,Instagram ,Centers For Disease ,Society For Maternal ,Exchange Commission ,American College Of Obstetrics ,Linkedin ,Safe Motherhood Initiative ,Twitter ,Facebook ,Agency For Healthcare Research ,Organon Medical Affairs ,Glob Health ,Womens Health ,World Health Organisation ,Department Of Obstetrics ,Columbia University Irving Medical Center ,American College ,Treating Abnormal Postpartum Uterine Bleeding ,Postpartum Hemorrhage ,Maternal Fetal Medicine ,Annual Pregnancy Meeting ,Post Hoc Analysis Supports Appropriate Control ,Loss Thresholds Prior ,Cumulative Blood Loss Prior ,Organon Medical ,System Instructions ,Securities Litigation Reform Act ,Annual Report ,Accessed July ,Prev Med ,Maternal Morbidity ,Updated July ,Care Consensus ,Obstetric Hemorrhage ,Accessed April ,Van Hook ,Updated February ,Market Registry ,Disease Control ,Healthcare Research ,Markets ,